Pharmedi & Healthcare Vietnam 2025 — Vietnam’s Gateway to Global Healthcare Innovation
2025-08-26
Date: September 24–27, 2025
Venue: Saigon Exhibition and Convention Center (SECC), District 7, Ho Chi Minh City, Vietnam
About the Exhibition
Pharmedi Vietnam (Pharmed & Healthcare Vietnam) is the largest and most influential international exhibition in the field of pharmaceuticals and healthcare in Vietnam. Officially supported by the Ministry of Health and the Ministry of Industry and Trade, the event serves as a comprehensive platform for showcasing the latest in medical equipment, pharmaceutical technologies, healthcare solutions, and biotechnological innovations.
The exhibition attracts a diverse mix of stakeholders — manufacturers, distributors, R&D institutions, healthcare providers, and policymakers — providing both a marketplace and a forum for knowledge exchange.
Key Highlights
1. Professional B2B Networking
Pharmedi Vietnam is recognized for its structured B2B matchmaking program, enabling exhibitors to meet directly with local distributors, international investors, and healthcare professionals. With more than 20,000 visitors expected, the exhibition offers high-value exposure and opportunities for market entry and expansion.
2. Global Market Access & Brand Building
The exhibition brings together companies from over 20 countries. For international brands, Pharmedi is a strategic entry point into Vietnam’s rapidly growing pharmaceutical and healthcare market, valued at billions of USD and projected to grow at double-digit rates. For local companies, it is an opportunity to benchmark and partner with global leaders.
3. Scientific Conferences & Knowledge Sharing
Alongside the exhibition, Pharmedi hosts specialized seminars, forums, and workshops where experts discuss new policies, healthcare strategies, clinical practices, and medical technologies. This combination of commerce and academia strengthens the event’s role as both a trade show and a knowledge hub.
4. Vietnam’s Rising Healthcare Industry
Vietnam’s healthcare expenditure has been increasing steadily, driven by demographic changes, rising incomes, and government commitment to expanding healthcare access. The pharmaceutical industry in particular is rapidly growing, with opportunities in generics, specialty drugs, and biologics. Pharmedi Vietnam is positioned as a key annual gathering to connect this fast-emerging market with the global healthcare supply chain.
Where Peptide Synthesizers Fit In
For companies in biopharmaceutical research and manufacturing, Pharmedi Vietnam provides a timely platform to introduce advanced laboratory and production equipment, including peptide synthesizers. Their relevance in the context of the exhibition can be summarized in several areas:
Accelerating Drug Discovery
Peptide synthesizers are essential for developing peptide-based drugs, vaccines, and diagnostic tools. Showcasing such instruments at Pharmedi highlights how Vietnam can move from generics toward innovation-driven drug discovery.
Supporting Clinical Research & Academia
With Vietnam increasingly investing in clinical trials and research infrastructure, peptide synthesizers provide universities and R&D labs with critical tools for developing novel therapeutic candidates.
Facilitating International Partnerships
Pharmedi’s B2B program offers opportunities to engage directly with pharmaceutical companies, contract research organizations (CROs), and biotech startups seeking reliable partners in peptide drug development.
Enabling Biotech Market Growth in Vietnam
As Vietnam’s pharmaceutical sector matures, advanced technologies like peptide synthesizers can help local firms upgrade capabilities, improve quality standards, and participate in global supply chains for biologics and innovative medicines.
Conclusion:
Pharmedi & Healthcare Vietnam 2025, taking place from September 24–27 at SECC, Ho Chi Minh City, is set to be a focal point for the healthcare and pharmaceutical industries in Vietnam and the wider region.
For companies specializing in peptide synthesis technology, the exhibition represents a strategic opportunity — not only to showcase equipment but also to contribute to Vietnam’s healthcare modernization, foster R&D collaborations, and build sustainable partnerships in one of Asia’s most promising pharmaceutical markets.
At the upcoming CPHI Shenzhen 2025 expo, the peptide sector will be a major focus. Peptides are increasingly used in biopharmaceuticals and health tech, especially in drug R&D, innovative therapies, and health product development. With global demand for peptide drugs rising, the expo offers a great exchange and collaboration platform for peptide - related companies, researchers, and investors.
google-site-verification: google4276cc4b6af705c5.html











